Private Market View

Sonire Therapeutics

Tokyo, Japan · Founded 2020 · Privately Held (backing)

Last price · $/share
Implied valuation
$31.7M
Total raised
$39.9M
Last round
Early Stage VC
Mar 2026
What is Sonire Therapeutics worth?
$31.7Mlast known valuation

Sonire Therapeutics last raised $13.5M in its Early Stage VC (Mar 2026).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 27 names
  • ·Watchlist + deal alerts for Sonire Therapeutics
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Mar 2026Early Stage VC$13.5M

How Sonire Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Sonire Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Sonire Therapeutics worth?
Sonire Therapeutics's last known valuation is $31.7M.
How much has Sonire Therapeutics raised?
Sonire Therapeutics has raised $39.9M in total funding across 1 recorded rounds.
When did Sonire Therapeutics last raise?
Sonire Therapeutics last raised in Mar 2026 (Early Stage VC), raising $13.5M.